Ageas reports on the progress of share buy-back programme
Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 72,457 Ageas shares in the period from 17-02-2025 until 21-02-2025.
Crypto Exchange OX.FUN Counters Extortion Allegations Amid Liquidity Concerns
OX.FUN said JefeDAO conducted an "oracle manipulation attack" through aggressive selling of JAILSTOOL tokens and violated its terms of service.
RAPID + TCT 2025 Offers Largest Conference Ever
DETROIT, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- RAPID + TCT 2025, North America's largest and most influential event for additive manufacturing ( AM ) , will return to Detroit's Huntington Place April 8-10.
Here's How Much You Would Have Made Owning Fortinet Stock In The Last 15 Years - Fortinet ( NASDAQ:FTNT )
Fortinet FTNT has outperformed the market over the past 15 years by 19.94% on an annualized basis producing an average annual return of 31.74%. Currently, Fortinet has a market capitalization of $83.64 billion.
On Holding's Options Frenzy: What You Need to Know - On Holding ( NYSE:ONON )
Whales with a lot of money to spend have taken a noticeably bullish stance on On Holding. Looking at options history for On Holding ONON we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and ...
Behind the Scenes of MercadoLibre's Latest Options Trends - MercadoLibre ( NASDAQ:MELI )
Investors with a lot of money to spend have taken a bullish stance on MercadoLibre MELI. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Snap Unusual Options Activity - Snap ( NYSE:SNAP )
Financial giants have made a conspicuous bearish move on Snap. Our analysis of options history for Snap SNAP revealed 9 unusual trades. Delving into the details, we found 44% of traders were bullish, while 55% showed bearish tendencies.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients - Medtronic ( NYSE:MDT )
Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS programming by 85%, reducing patient time spent in clinics.
